![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » NEUROBIOLOGICAL TECHNOLOGIES, INC. RECEIVES $4 MILLION MILESTONE PAYMENT FROM CELTIC PHARMA FOR XERECEPT
NEUROBIOLOGICAL TECHNOLOGIES, INC. RECEIVES $4 MILLION MILESTONE PAYMENT FROM CELTIC PHARMA FOR XERECEPT
Neurobiological Technologies, Inc. today announced it has received $4 million from Celtic Pharmaceutical Holdings L.P. (Celtic Pharma) as part of Neurobiological Technologies' previously announced sale of worldwide rights to Celtic Pharma for Xerecept, a Phase III clinical compound for the treatment of peritumoral brain edema.
Yahoo News
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct